期刊文献+

肥胖患者血清游离胰岛素样生长因子Ⅰ及其结合蛋白水平与代谢因素的关系 被引量:3

Serum levels of free insulin-like growth factor- 1 and its binding proteins and their relationships to metabolic factors in obese patients
原文传递
导出
摘要 目的 观察肥胖患者血清游离胰岛素样生长因子Ⅰ(IGF-Ⅰ)、胰岛素样生长因子结合蛋白1(IGFBP-1)及IGFBP-3水平,分析其与年龄、性别、体重指数(BMI)、糖代谢、脂代谢等指标的关系。方法应用ELSA法测定97例肥胖患者和84例正常人血清游离IGF-Ⅰ、IGFBP-3、IGFBP-1、真胰岛素和血脂水平。结果 肥胖组与对照组比较,IGFBP-3明显增高(P<0.01),IGFBP-1下降(P<0.05),而游离的IGF-Ⅰ水平差异无显著性。游离IGF-Ⅰ水平与年龄呈显著负相关(正常组r=-0.26,P<0.05;肥胖组r=-0.42,P<0.01)。在肥胖组,游离IGF-Ⅰ水平与空腹血糖(r=-0.31,P<0.01)、低密度脂蛋白(r=-0.23,P<0.05)及IGFBP-1(r=-0.24,P<0.05)呈负相关,IGFBP-1与BMI(r=-0.41,P<0.01)、空腹胰岛素(FINS)(r=-0.35,P<0.01)和Homa-IR指数呈负相关(r=-0.31,P<0.01),IGFBP-3与FINS呈正相关(r=0.26,P<0.05)。结论 游离IGF-Ⅰ水平随年龄的增长有下降的趋势,并可能参与糖代谢及脂代谢的调节。IGFBP-1浓度可能反映胰岛素抵抗状态。 Objective To observe serum free insulin-like growth factor (ICF)- I , ICF binding protein ( BP)-1 , ICFBP-3 levels in obese and normal subjects, and to evaluate their possible relationships to age, sex, hotly mass index ( BM1),fat distribution, glucose and lipid metabolism in obese patients. Methods Ninety-seven obese outpatients (57 females and 40 males aged 18-71,BM1>25 but <40kg/m2) and 84 healthy subjects (36 females and 48 males aged 18-67, BMI > 18. 5 but <23 kg/m2) were recruited. Their BMI, waist-hip ratio (WHR), blood pressure (BP), serum glucose and insulin levels during oral glucose tolerance test, free ICF-I, IGFBP-1, ICFBP-3, total cholesterol, triglyceride, low density lipoprotein (LDL), high density lipoprotein (HDL) and uric acid levels were measured. Results Comparing with control, ICFBP-3 was significantly increased (P<0.01) while IGFBP-1 decreased (P<0.05), and free ICF- I level was not varied in obesity patients. Free IGF- I level was negatively correlated with age (normal group r = -0.26, P<0.05; obesity group r= -0. 42,P <0.01). Free ICF- [ level was negatively correlated with fasting plasma glucose(r = -0.31, P <0. 01 ) , LDL(r= -0.23, P <0. 05) and ICFBP-1 (r= -0.24, P < 0. 05) , and ICFBP-1 was negatively correlated with BMI ( r = -0. 41 , P <0. 01 ) and fasting insulin ( FINS) ( r = -0. 35 , P <0. 01 ) and Homa-IR (r= -0.31, P<0.01), while ICFBP-3 was positively correlated with FINS (r=0.26, P < 0. 05 ) in obesity group. Conclusion Free IGF- I level shows negative correlation with age, and it may play a role in the regulation of glucose and lipid metabolism, ICFBP-1 concentrations may reflect insulin resistance status.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2003年第3期184-186,共3页 Chinese Journal of Endocrinology and Metabolism
基金 青岛市科委科技发展项目资助(00w11)
关键词 肥胖 血清 游离胰岛素样生长因子Ⅰ 胰岛素样生长因子结合蛋白1 胰岛素抵抗 Obesity Insulin resistance Insulin-like growth factor- I Insulin-like growth factor binding protein-1 Insulin-like growth factor binding protein-3
  • 相关文献

参考文献10

  • 1Scacchi M, Pincelli AI, Cavagnini F. Growth hormore in obesity, Int J Obes, 1999,23:260-271.
  • 2Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocrinol Rev, 1995,16:3-34.
  • 3Veldhuis JD, Liem AY, South S, et al. Differential impact of age, sex steroid hormone, and obesity in basal versus pulsatile growth hormone secretion in men as assessed in an ultra-sensitive chemiluminescence assay. J Clin Endocrinol Metab, 1995,80:3209-3222.
  • 4Rosen CJ, Pollak M. Circulating IGF-1 : new perspectives for a new century. Trends Endocrinol Metab, 1999,10:136-141.
  • 5Lang CH, Fan J, Frost RA, et al. Regulation of the insulin-like growth factor system by insulin in burn patients. J Clin Endocrinol Metab,1996,81:2474-2480.
  • 6Scharf JG, Ramadori G, Brauike T, et al. Cellular hxzalization and hormonal regulation of biosynthesis of insulin-like growth factor binding proteins and of acid-labile subunit within rat liver. Prog Growth Factor Res, 1995,6:175-180.
  • 7Giukice LC. IGF binding protein-3 protease regulation : how sweet it is ! J Clin Endocrinol Metab, 1995,80:2279-2281.
  • 8Brismar K, Hall K. Clinical applications of IGFBP-1 and its regulation.Growth Regul, 1993,3:98-100.
  • 9Lee PD, Conover CA, Powell DR, et al. Regulation and function of insulin-like growth factor-binding protein-1, Proc Soc Exp Biol Med,1993,204 : 4 -29.
  • 10Sasaoka T, Kobayashi M, Takata Y, et al. Clarification of signalling pathways mediated by insulin and IGF-1 receptors in fibroblasts from patients with specific defect in insulin receptor. Diabetes, 1998,37:1515-1523.

同被引文献19

  • 1黄志红,桂影,张国增,白慧玲.老年患者围术期中生长激素的应用及对预后的影响[J].中国老年学杂志,2014,34(9):2346-2348. 被引量:2
  • 2Henderson D C, Xiaoduo Fan, Paul M, et ah Aripiprazole added to o- verweight and obese olanzapine - treated schizophrenia patients [ J ]. JClin Psyehopharmaeol, 2009,29 ( 2 ) : 165-169.
  • 3David C, Henderson M, Xiaoduo Fan, et al. AJripiprazole added to over - weight and obse olanzapine - treated schizophrenia patients [ J ]. J Clin Psychopharmacology ,2009,29 ( 2 ) : 165-169.
  • 4陆静尔,任跃忠.胰岛素样生长因子与胰岛素抵抗研究进展[J].2008,30(9):1025-1026.
  • 5Moses A C. Insulin resistance and type2 diabetes mellitus:Is there a therapeutic role for IGF I[J]. Endocr Dev,2005,9(2) :121-134.
  • 6Perez - Iglesias R, Mata I, Pelayo - Teran J M, et al. Glucose and lipid disturbances after 1 year of antipsychotie treatment in a drug - naiive population [ J ]. Schizophr Res,2008,102 ( 1-3 ) : 329-336.
  • 7Sjogren K, Wallenius K, Liu J L, et al. Liver - derived IGF - I is of importance for normal carbohydrate and: lipid metabolism[ J]. Diabe- tes,2001,50(7) :1539-1545.
  • 8Lee J H, Woo J I, Mehzer H Y, et al. Effects of clozapine on sleep measures and sleep associated changes in growth hormone and cortisol in patients with schizophrenia [ J ]. Psychiatry Res, 2001, 103 ( 2 ) : 157-166.
  • 9纪菊英,宋梓祥,徐乐平,孙剑,施建安,赵汉清,王焕林.阿立哌唑治疗利培酮所致精神分裂症女性患者高催乳素血症的研究[J].中华精神科杂志,2008,41(3):169-171. 被引量:23
  • 10付文亮,付秀美,和亚强,马洪伟,陈志宏.生长激素/胰岛素样生长因子-1轴与糖尿病研究进展[J].中国老年学杂志,2010,30(19):2869-2872. 被引量:12

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部